Skip to main content

Polaris Capital Management, LLC

Position in SUPN — Supernus Pharmaceuticals, Inc.

CIK 1316926 BOSTON, MA

Position in SUPN

as of Mar 31, 2026 · filed Apr 27, 2026
Position Value
$1,163,025
-$119,235 QoQ
Shares Held
22,500
-12.8% QoQ
Ownership
0.039%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Jun 2021
20 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in SUPN Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

Polaris Capital Management, LLC holds $107,320,546 across 5 Drug Manufacturers - Specialty & Generic names. SUPN ranks #4 (1.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
4 SUPN
Supernus Pharmaceuticals, Inc.
This page
22,500 $1,163,025

All Filings in SUPN

Export CSV
20 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $1,163,025 22,500
2025-12-31 $1,282,260 25,800
2025-09-30 $1,232,982 25,800
2025-06-30 $1,358,512 43,100
2025-03-31 $1,411,525 43,100
2024-12-31 $1,699,520 47,000
2024-09-30 $1,325,150 42,500
2024-06-30 $1,136,875 42,500
2024-03-31 $1,449,675 42,500
2023-12-31 $1,229,950 42,500
2023-09-30 $1,171,725 42,500
2023-06-30 $1,277,550 42,500
2023-03-31 $1,539,775 42,500
2022-12-31 $1,515,975 42,500
2022-09-30 $1,113,665 32,900
2022-06-30 $951,468 32,900
2022-03-31 $1,063,328 32,900
2021-12-31 $959,364 32,900
2021-09-30 $877,443 32,900
2021-06-30 $1,012,991 32,900